Sagicor Financial Company Ltd. Overview
Sagicor Financial is a mid-sized, multi-jurisdictional life and health insurance group that has transformed itself over seven years from a Caribbean-centric conglomerate into a three-pillar platform spanning Canada, the United States and the Caribbean. Its Canadian unit, ivari, acquired from Wilton Re in 2023, is a middle-market individual life and critical illness insurer and is now the group's largest core earnings contributor. Sagicor Life USA is a spread-based fixed annuity and life writer growing rapidly through independent distribution. In the Caribbean, the group holds a market-leading franchise through Sagicor Life Inc. (southern and eastern Caribbean) and a 49.1% controlling stake in the Jamaica-listed Sagicor Group Jamaica, a diversified insurer, bank and investment house. The investment thesis rests on core return-on-equity expansion toward 14% in 2027 and 15% in 2028, a simplified Caribbean structure, improving credit ratings, and a share price trading well below book value.
Company's own description. In its standard disclosure language, Sagicor describes itself as a leading financial services provider in Canada, the United States and the Caribbean, with more than 185 years of history in the Caribbean, more than 90 years in Canada and more than 70 years in the United States. It lists its offering as life, health and general insurance, banking, pensions, annuities, investment management and real estate (FY2025 results release, 11 March 2026; Q2 2026 release).
Independent characterization. Functionally, Sagicor is a holding company whose earnings derive from four regulated operating segments plus a head-office layer carrying parent-level debt service and corporate costs:
Sagicor Canada (ivari): a closed-architecture, broker-distributed manufacturer of individual protection products (universal life, term life, critical illness) for the Canadian middle market. It earns insurance service results through release of the contractual service margin (CSM) and risk adjustment, plus spread on general-account assets backing long-duration liabilities.
Sagicor Life USA: an annuity-led spread business (fixed and fixed-indexed annuities) supplemented by life insurance, distributed via independent marketing organizations and agents. Earnings growth is driven by assets under management (AUM) accumulation; new business production was US$1.3 billion in FY2025.
Sagicor Jamaica: a 49.1%-owned (consolidated) diversified financial group: life and health insurance, pensions, annuities, property & casualty insurance, commercial banking (Sagicor Bank Jamaica), investment banking/brokerage and asset management, and real-estate investment, operating in Jamaica and also Cayman Islands, Panama, Costa Rica and the US (per segment description in third-party profiles).
Sagicor Life: the wholly owned southern/eastern Caribbean life, health, annuity and pension operations (Sagicor Life Inc., founded 1840), plus general insurance in Barbados (Sagicor General Insurance Inc.). Sagicor Life Inc. operates in 11 countries, primarily Trinidad & Tobago, Barbados and the Eastern Caribbean (company release, 16 Dec 2025).
Revenue model. Revenue is overwhelmingly insurance- and investment-based rather than product/subscription/licensing. The company defines "revenues" as the sum of insurance revenue, net investment income, and fees and other income. In H1 2026 these were US$779.3 million, US$957.2 million and US$88.1 million respectively (total US$1,824.6 million), illustrating that reported revenue is dominated by mark-to-market-sensitive net investment income under IFRS 17/IFRS 9 rather than by premiums (Q2 2026 release). Fee income is concentrated in Sagicor Jamaica (banking and asset management fees: US$66.1 million of the US$88.1 million H1 2026 group fees).
Approximate revenue mix (H1 2026, company-defined revenues):
Source: Q2 2026 news release (revenues reconciliation), 12 Aug 2026. Shares derived.
Value-chain position. Sagicor is a primary insurer (product manufacturer and risk carrier) with captive and independent distribution in the Caribbean (tied agency, bancassurance via Sagicor Bank in Jamaica, brokers), independent brokerage in Canada (MGAs/advisors) and independent marketing organizations in the US. It uses reinsurance actively — including an in-house Bermuda reinsurer, Sagicor Reinsurance Bermuda Ltd. (SRBL), which AM Best describes as optimizing group-wide capital under a capital maintenance agreement with the parent (AM Best release, 16 Jul 2026). Asset management is largely in-house for the Caribbean.
Customer types and end-markets. Retail middle-market individuals (all segments), employer groups (group life/health and pensions in the Caribbean), retirement savers (US annuities, Caribbean annuities/pensions), banking clients (retail and commercial, Jamaica), and property & casualty clients (Jamaica, Barbados).
Strategy
Stated strategy. Management's current strategic framing, articulated in the FY2025 results and 2026 earnings calls, rests on three themes: (1) return-on-equity expansion, with targets of 14% core ROE in 2027 and 15% core ROE in 2028 (originally framed as "15% over the medium term"); (2) Caribbean transformation, enabled by combining Sagicor Jamaica and Sagicor Life into Sagicor Group Caribbean and executing a digital transformation of those businesses; and (3) continued organic growth in North America, especially US annuities and Canadian protection. Management stated that each growth lever is expected to add roughly 1–2 percentage points to core ROE over the next three to five years (Quartr Q2 2026 summary).
Strategic initiatives in the last 24 months.
Medium-term financial targets / guidance.
Sustainability/ESG commitments. No quantified emissions targets or sustainability-linked financing were identified in sources reviewed.
Cost programmes. No standalone quantified cost-reduction target has been disclosed in sources reviewed; synergy targets for the Caribbean combination have not been quantified publicly in the materials reviewed.
Products & Services
Product-level specifications, launch years and pricing are not disclosed by Sagicor in its investor filings; the following catalog is assembled from segment descriptions and public company materials. Specific retail brand names are listed only where verified.
Sagicor Canada (ivari)
| Product line | Description | Target customer | Distribution | Notes |
|---|---|---|---|---|
| Universal life insurance (ULI) | Permanent life with tax-advantaged investment account; policyholder fund values linked to market indices/accounts | Middle-market families, small-business owners | Independent advisors via MGAs | Equity-market sensitivity of UL fund balances drove Q2 2026 net income gains |
| Term life insurance | Level-premium term protection (multiple durations) | Middle-market, mortgage-protection buyers | Independent advisors | Core new-business driver |
| Critical illness insurance | Lump-sum benefit on diagnosis of covered conditions | Middle-market individuals | Independent advisors | ivari is a recognized CI carrier in Canada |
| Insurance planning tools | Advisor illustration/planning support | Advisors | Direct to advisor | Per third-party profile (CB Insights) |
| Legacy segregated funds/annuities | In-force blocks inherited from Transamerica Life Canada heritage | Existing policyholders | Closed/legacy | Contributes to market sensitivity |
ivari originated as Transamerica Life Canada (sold by Aegon to Wilton Re in 2015 for C$600 million and rebranded; Investment Executive, Aug 2022). At acquisition announcement, ivari had C$13.9 billion of total assets and C$968 million of gross premium revenue for 2021, and C$74 million of 2021 net income (company acquisition release, Aug 2022).
Sagicor Life USA
| Product line | Description | Target customer | Distribution | Notes |
|---|---|---|---|---|
| Fixed / multi-year guaranteed annuities | Spread-based deferred annuities with guaranteed crediting periods | Pre-retirees and retirees | Independent marketing organizations, agents | Main driver of US$1.3bn FY2025 new business production |
| Fixed indexed annuities | Index-linked crediting with principal protection | Retirement savers | IMOs, agents | — |
| Life insurance (term and permanent; legacy blocks) | Individual life, including legacy in-force | Middle-market | Independent agents | Legacy life block (incl. term issued 2016–2020) produced experience losses in Q2 2026 (MarketBeat call summary, Aug 2026) |
Sagicor Jamaica (Sagicor Group Jamaica)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Individual life & health | Protection and savings products | Jamaican households | Market leader in Jamaican life insurance (company characterization) |
| Group life, health and employee benefits | Employer-sponsored coverage | Corporates, public sector | Short-term repricing improved margins in 2025 |
| Annuities and pensions | Retirement income, pension administration | Retirees, pension plans | — |
| Property & casualty insurance | General insurance (motor, property) | Individuals and businesses | Exposed to hurricane catastrophe risk |
| Commercial banking (Sagicor Bank Jamaica) | Deposits, loans, cards, payments | Retail and commercial clients | Loan and card portfolio expansion with higher NIM in 2025 (FY2025 release) |
| Investment banking, brokerage, asset management | Securities brokerage, unit trusts, wealth management | Retail and institutional investors | Fee income contributor |
| Real estate investment | Hotel/real-estate investment vehicles | Investors | Specific asset list not re-verified |
| Regional operations | Cayman Islands, Panama, Costa Rica, US (per third-party segment description) | — | — |
Sagicor Life (Southern and Eastern Caribbean)
| Product line | Description | Target customer | Notes |
|---|---|---|---|
| Individual life | Protection and savings | Households across 11 countries | — |
| Group life and health | Employee benefits | Employers | Short-term repricing initiatives lifted 2025 profitability |
| Single-premium annuities | Retirement income | Retirees | Key 2025–2026 growth driver (Q2 2026 release) |
| Pensions | Group pension administration and investment | Employers, pension trustees | — |
| General insurance (Sagicor General Insurance Inc., Barbados) | Property and casualty | Barbadian individuals and businesses | Upgraded to A (Excellent) by AM Best, Jul 2026 |
| Asset management | Investment management for Caribbean clients | Retail/institutional | — |
Group-level / Head Office
| Offering | Description |
|---|---|
| Sagicor Reinsurance Bermuda Ltd. | Intra-group reinsurer optimizing group capital; AM Best FSR A- (Excellent), affirmed Jul 2026 |
Financial Narrative
Income statement and per-share metrics
Sources: FY2025 release (11 Mar 2026) and FY2024 release (13 Mar 2025) for company metrics; TipRanks income statement for FY2021–FY2024 net income, EPS, pre-tax income and share counts (aggregator; IFRS 4/17 basis not specified by vendor); FY2023 core metrics derived from the 84% (core earnings) and 87% (core EPS) growth rates disclosed for FY2024; FY2025 basic EPS derived as US$66.9 million ÷ approx. 135.7 million weighted shares (itself derived from core earnings ÷ core EPS). FY2023 net income of US$532 million is confirmed in the FY2023 Annual Report, which attributes it largely to the ivari bargain purchase gain.
Revenue CAGR. A five-year revenue CAGR cannot be computed on a consistent basis (accounting standard change and the ivari acquisition). Company-defined revenue declined 3.0% in FY2025 (US$3,098.8 million → US$3,005.4 million), entirely because of lower net investment income in Canada; net premium grew 23.1% (derived) on the back of a 45% jump in US annuity premium.
Margins. On company-defined revenues, the core earnings margin was 2.9% in FY2024 and 4.7% in FY2025 (derived); the net income margin was 3.1% and 2.2% respectively. Gross, operating and EBITDA margins are not meaningful for an insurer.
Trend commentary. The defining trend is the step-change in core earnings — from roughly US$49 million in FY2023 to US$142.3 million in FY2025 (nearly a tripling) — driven by a full year of ivari consolidation in 2024 and broad segment improvement in 2025. FY2025 core earnings beat management's revised guidance of US$120–130 million, aided by about US$15 million of favourable insurance experience and short-term business gains (CEO commentary, FY2025 release). Reported net income has been far more volatile: an FY2022 loss (rising rates under the restated basis), an FY2023 peak inflated by a non-recurring bargain purchase gain, and FY2024–FY2025 results that undershot or roughly matched core earnings depending on market experience. In FY2025 the gap between core (US$142.3 million) and net (US$66.9 million) was explained mainly by market experience losses (US$39.0 million) and "other" items (US$44.6 million: acquisition/integration/restructuring, intangible amortization, financing costs, tax items), partly offset by assumption changes (FY2025 reconciliation).
Quarterly trajectory, 2025–2026: notes and sources
Notes: Q1 2025 net income (US$6.7 million) and new business CSM (US$46.1 million) derived from H1 2025 less Q2 2025; Q1 2026 net loss derived as H1 2026 net income (US$52.2 million) less Q2 2026 (US$86.6 million). Sources: Q2 2026, Q1 2026 and FY2025 releases; Quartr (Q1 2025 core earnings of US$29.7 million).
Balance sheet and capital
Sources: FY2025 release (11 Mar 2026), including the non-IFRS definitions section (total capital of approx. US$3.7 billion = shareholders' equity US$1.0 billion + notes and loans payable US$999 million + NCI US$399 million + net CSM US$1.3 billion).
At 30 June 2026: shareholders' equity US$1,039.3 million; net CSM US$1,263.2 million; net CSM to shareholders US$1,106.5 million; equity plus net CSM to shareholders US$2,145.8 million; BVPS US$7.65 / C$10.87; LICAT 134%; leverage 27.4%; total capital approx. US$3.7 billion including notes and loans payable of approx. US$1.0 billion and NCI of US$407 million (Q2 2026 release). Cash and equivalents of US$692.8 million and total debt of US$1.49 billion are cited by a third-party vendor (Motley Fool quote page, Aug 2026).
Goodwill and intangibles; working capital. Not disclosed in sources reviewed. Working capital is not a meaningful concept for an insurer.
Net debt. Not computed: holding-company cash is not disclosed in sources reviewed, and consolidated cash includes regulated subsidiary and bank cash not available to service parent debt.
Debt issued after 30 June 2026. C$350 million (approx. US$255 million at prevailing rates; conversion is an analyst estimate) of 5.503% notes due 2031 closed on 25 September 2026. Use of proceeds is not stated in the closing release reviewed; refinancing of part of the US$550 million 2028 notes or the ivari acquisition bank term debt is plausible but unconfirmed. Pro forma leverage will depend on the use of proceeds.
Cash flow and capital return
Sources: FY2024 release (3.0 million shares repurchased in 2024, contributing to a 4% net reduction in share count); FY2025 earnings call summary (over US$40 million returned via dividends and buybacks in 2025 — figure is a floor). Operating cash flow, capex and free cash flow are not disclosed in the sources reviewed and are of limited analytical value for an insurer; holding-company free cash flow/remittance data are not publicly disclosed in sources reviewed.
NCIB activity detail: under the June 2024–June 2025 NCIB, 2,545,600 shares were bought at a weighted average of C$5.89 (C$15.0 million); under the June 2025–June 2026 NCIB, 1,113,340 shares at C$8.01 (C$8.9 million) through 10 June 2026 (NCIB renewal releases, Jun 2025 and Jun 2026). Q4 2025 repurchases were 109,300 shares (approx. US$0.7 million); Q2 2026 repurchases were 496,340 shares (US$2.9 million).
Ratios
ROA, ROIC, current ratio, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: not disclosed and/or not meaningful for an insurer. Fixed-charge coverage is a rating driver cited by DBRS but the ratio itself is not publicly disclosed in sources reviewed.
Commentary on capital. Capital adequacy has drifted modestly lower (LICAT 139% → 136% → 134%) while leverage has improved slightly (27.3% → 26.9% → 27.4%). Management has framed its capital posture as maintaining LICAT above 130% and leverage below 30% (Insurance Business, Mar 2026). The mild LICAT erosion partly reflects US annuity growth consuming capital and the Q1 2026 market loss; the planned Caribbean combination and reinsurance contract modifications at Sagicor Life (which reduced that segment's net CSM by 7% QoQ in Q2 2026) are described by management as Caribbean "balance sheet cleanup" ahead of the merger (Jamaica Observer, Aug 2026).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Legal entities (principal) | Ownership | What it contains |
|---|---|---|---|
Sagicor Canada | ivari (Toronto) | 100% | Individual life (universal life, term), critical illness, legacy annuities and segregated funds; broker distribution |
Sagicor Life USA | Sagicor Life Insurance Company (Austin, Texas) | 100% | Fixed and fixed-indexed annuities, life insurance in licensed US states |
Sagicor Jamaica | Sagicor Group Jamaica Ltd (JSX: SJ) and subsidiaries (Sagicor Life Jamaica, Sagicor Bank Jamaica, Sagicor Investments Jamaica, general insurance and real-estate vehicles) | 49.1% (consolidated) | Life, health, annuity, pensions, P&C, commercial banking, investment banking/brokerage, asset management, real estate |
Sagicor Life | Sagicor Life Inc. (Barbados) and Sagicor General Insurance Inc. | 100% | Southern/eastern Caribbean life, health, annuities, pensions; Barbados general insurance |
Head Office & Other | Sagicor Financial Company Ltd., Sagicor Reinsurance Bermuda Ltd., financing vehicles, consolidation adjustments | — | Parent financing costs, corporate expenses, other operations not attributed to segments |
Segment revenue (USD Mn)
| Segment revenue (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Sagicor Canada | 1,422.5 | 1,200.2 |
Sagicor Life USA | 520.6 | 553.0 |
Sagicor Jamaica | 706.2 | 794.3 |
Sagicor Life | 448.3 | 485.3 |
Head Office and adjustments | 1.2 | -27.4 |
Total | 3,098.8 | 3,005.4 |
Segment Revenue
| Segment | FY2024 share (%) | FY2025 share (%) | FY2025 YoY growth (%) |
|---|---|---|---|
Sagicor Canada | 45.9 | 39.9 | -15.6 |
Sagicor Life USA | 16.8 | 18.4 | 6.2 |
Sagicor Jamaica | 22.8 | 26.4 | 12.5 |
Sagicor Life | 14.5 | 16.1 | 8.3 |
Head Office | 0.0 | -0.9 | — |
Segment core earnings (USD Mn)
| Segment core earnings (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Sagicor Canada | 86.9 | 103.3 |
Sagicor Life USA | 40.2 | 41.0 |
Sagicor Jamaica (Sagicor share) | 31.1 | 47.9 |
Sagicor Life | 26.3 | 41.8 |
Head Office | -93.6 | -91.7 |
Total | 90.9 | 142.3 |
Segment net income (USD Mn)
| Segment net income (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Sagicor Canada | 96.2 | 76.2 |
Sagicor Life USA | 51.6 | 8.2 |
Sagicor Jamaica (Sagicor share) | 31.3 | 50.7 |
Sagicor Life | 38.5 | 57.4 |
Head Office | -120.1 | -125.6 |
Total | 97.5 | 66.9 |
Revenue by Segment
| Segment net premium (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Sagicor Canada | 422.6 | 431.0 |
Sagicor Life USA | 896.2 | 1,298.3 |
Sagicor Jamaica | 358.0 | 383.5 |
Sagicor Life | 405.7 | 450.2 |
Total | 2,082.5 | 2,563.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment by Segment New Business CSM
| Segment new business CSM (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Sagicor Canada | 45.9 | 44.4 |
Sagicor Life USA | 36.8 | 31.4 |
Sagicor Jamaica | 41.0 | 49.6 |
Sagicor Life | 42.6 | 41.8 |
Total | 166.3 | 167.2 |
Segment Revenue (FY2024 (%)–FY2025 (%))
| Segment | FY2024 (%) | FY2025 (%) |
|---|---|---|
Sagicor Canada | 6.1 | 8.6 |
Sagicor Life USA | 7.7 | 7.4 |
Sagicor Jamaica | 4.4 | 6.0 |
Sagicor Life | 5.9 | 8.6 |
Segment Revenue (Half-Yearly)
| Segment | H1 2025 core | H1 2026 core | H1 2025 net income | H1 2026 net income | H1 2026 revenues | H1 2026 net premium |
|---|---|---|---|---|---|---|
Sagicor Canada | 49.2 | 49.0 | 14.6 | 69.6 | 969.0 | 230.5 |
Sagicor Life USA | 22.6 | 10.9 | -0.9 | -1.7 | 204.1 | 582.7 |
Sagicor Jamaica | 24.1 | 19.6 | 27.1 | 15.2 | 399.9 | 207.7 |
Sagicor Life | 26.3 | 24.0 | 28.2 | 14.1 | 245.5 | 218.5 |
Head Office | -46.5 | -44.4 | -68.7 | -45.0 | 6.1 | 0.0 |
Total | 75.7 | 59.1 | 0.3 | 52.2 | 1,824.6 | 1,239.4 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenues, company-defined (USD Mn) | — | — | — | 3,098.8 | 3,005.4 |
Net premium (USD Mn) | — | — | — | 2,082.5 | 2,563.0 |
New business CSM (USD Mn) | — | — | — | 166.3 | 167.2 |
Core earnings to shareholders (USD Mn; FY2023 derived) | — | — | 49.4 | 90.9 | 142.3 |
Pre-tax income (USD Mn; aggregator) | 264.7 | -112.4 | 673.4 | 190.1 | — |
Net income to shareholders (USD Mn) | 132.6 | -164.4 | 532.1 | 97.5 | 66.9 |
Basic EPS (USD; FY2025 derived) | 0.92 | -1.15 | 3.74 | 0.70 | 0.49 |
Diluted EPS (USD) | 0.91 | -1.15 | 3.67 | 0.68 | — |
Core basic EPS (USD cents; FY2023 derived) | — | — | 34.7 | 64.9 | 104.9 |
Core ROE (%) | — | — | — | 9.6 | 14.2 |
Total comprehensive income to shareholders (USD Mn) | — | — | — | — | 109.7 |
| — | 0.05625 | 0.05625 | 0.05625 | 0.06 | 0.0675 |
Weighted avg basic shares (M; aggregator, FY2025 derived) | 146.83 | 142.91 | 144.98 | 140.06 | 135.7 |
Returns & Leverage Ratios (%)
| Metric | Q1 2025 | Q2 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Core earnings to shareholders | 29.7 | 46.0 | 31.6 | 24.9 | 34.2 |
Net income to shareholders | 6.7 | -6.4 | -14.4 | -34.4 | 86.6 |
Core ROE annualized (%) | — | 18.9 | 12.1 | 9.9 | 13.6 |
New business CSM | 46.1 | 39.2 | 41.3 | 36.7 | 44.0 |
Balance Sheet and Per-Share Data
| Metric | FY2024 | FY2025 |
|---|---|---|
Shareholders' equity (USD Mn) | 959.7 | 1,036.6 |
Net CSM (USD Mn) | 1,219.7 | 1,271.8 |
Net CSM to shareholders (USD Mn) | 1,076.1 | 1,122.9 |
Shareholders' equity plus net CSM to shareholders (USD Mn) | 2,035.8 | 2,159.5 |
Book value per share (USD) | 7.08 | 7.65 |
Notes and loans payable (USD Mn) | — | 999 |
Non-controlling interests (USD Mn) | — | 399 |
Total capital (USD Mn) | — | 3,700 |
Group LICAT ratio (%) | 139 | 136 |
Financial leverage ratio (%) | 27.3 | 26.9 |
Shares outstanding at year end (M) | — | 135.4 |
Share Count (M) and Dividends & Capital Returns
| Metric | FY2024 | FY2025 |
|---|---|---|
Shares repurchased (M) | 3.0 | — |
Dividends plus buybacks returned to shareholders (USD Mn) | — | 40 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 | Basis |
|---|---|---|---|
Core ROE (%) | 9.6 | 14.2 | Company-reported |
Reported ROE (%) | — | 6.7 | Derived: net income ÷ average of opening/closing shareholders' equity |
Financial leverage ratio (%) | 27.3 | 26.9 | Company-reported (notes and loans payable ÷ total capital incl. net CSM) |
Debt / shareholders' equity (x) | — | 0.96 | Derived: US$999M ÷ US$1,036.6M |
Debt / total equity incl. NCI (x) | — | 0.70 | Derived |
Core dividend payout ratio (%) | — | 25.7 | Derived: annualized US 27¢ (2025 rate) ÷ 104.9¢ core EPS |
Price / book (x, Oct 2026) | — | 0.77 | Derived: C$8.42 ÷ C$10.87 BVPS (Q2 2026) |
Region revenue (USD Mn)
| Region revenue (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Canada | 1,422.5 | 1,200.2 |
United States | 520.6 | 553.0 |
Caribbean (Jamaica plus Sagicor Life) | 1,154.5 | 1,279.6 |
Head Office and adjustments | 1.2 | -27.4 |
Total | 3,098.8 | 3,005.4 |
Revenue by Region (%)
| Region (%) | FY2024 share (%) | FY2025 share (%) |
|---|---|---|
Canada | 45.9 | 39.9 |
United States | 16.8 | 18.4 |
Caribbean | 37.3 | 42.6 |
Revenue by Region
| Region net premium (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Canada | 422.6 | 431.0 |
United States | 896.2 | 1,298.3 |
Caribbean | 763.7 | 833.7 |
Total | 2,082.5 | 2,563.0 |
Region core earnings (USD Mn)
| Region core earnings (USD Mn) | FY2024 | FY2025 |
|---|---|---|
Canada | 86.9 | 103.3 |
United States | 40.2 | 41.0 |
Caribbean | 57.4 | 89.7 |
Capital Markets
| Measure | Value | Source / as-of |
|---|---|---|
Last price | C$8.42 | Close 13 Oct 2026 (WealthAwesome) |
YTD 2026 | approx. -15% | WealthAwesome, 9 Oct 2026 |
1-year | approx. +3% | Motley Fool quote page (as of approx. Aug 2026) |
5-year | approx. +68% | Motley Fool quote page (as of approx. Aug 2026) |
Since TSX listing (2019) | approx. +28% | Motley Fool quote page |
52-week range | C$7.21 – C$10.53 | Motley Fool quote page |
Reference closes | C$9.71 (11 Mar 2026); C$9.46 (13 May 2026); C$8.44 (22 Jun 2026); C$8.44 (16 Sep 2026) | Stockwatch; MarketScreener |
Beta | 0.27 | Motley Fool quote page |
Share price (CAD, reference close) | Mar 2026 | May 2026 |
SFC close | 9.71 | 9.46 |
Valuation Multiples
| Multiple | Sagicor | Basis |
|---|---|---|
P/E 2026E | 7.5x | MarketScreener consensus |
P/E 2027E | 6.0x | MarketScreener consensus |
P/E trailing (reported) | approx. 32.7x | Motley Fool (TTM net income US$26.1M — depressed by market losses) |
P/B (on Q2 2026 BVPS C$10.87) | 0.77x | Derived |
Price / (equity + net CSM per share, C$21.87 at FY2025) | approx. 0.38x | Derived |
EV/EBITDA, EV/Sales | not meaningful for insurers | — |
Quarterly dividend per share (USD)
| Quarterly dividend per share (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Rate in effect at year end (FY2026 = current) | 0.05625 | 0.05625 | 0.05625 | 0.06 | 0.0675 | 0.075 |
Ncib Period Details
| NCIB period | Max shares | Executed (to date of renewal) | Avg price |
|---|---|---|---|
24 Jun 2024 – 23 Jun 2025 | 8,951,359 | 2,545,600 | C$5.89 |
24 Jun 2025 – 23 Jun 2026 | 9,296,291 | 1,113,340 | C$8.01 |
24 Jun 2026 – 23 Jun 2027 | 9,188,420 | In progress | — |
Credit Ratings
| Agency | Entity / instrument | Rating | Outlook / trend | Date |
|---|---|---|---|---|
AM Best | SFC Long-Term ICR | bbb (Good), up from bbb- | Stable | 16 Jul 2026 |
AM Best | US$550M 5.30% senior notes due 2028 | bbb+, up from bbb | Stable | 16 Jul 2026 |
AM Best | ivari, Sagicor Life Insurance Co., Sagicor Life Inc., Sagicor General Insurance Inc. — FSR | A (Excellent), up from A- | Stable | 16 Jul 2026 |
AM Best | Sagicor Reinsurance Bermuda Ltd. — FSR | A- (Excellent), affirmed | Stable | 16 Jul 2026 |
AM Best | Sagicor Life Jamaica — FSR | B++ (Good), affirmed | Stable | 16 Jul 2026 |
Morningstar DBRS | SFC issuer and senior debt | BBB, up from BBB (low) | Stable | Apr 2026 |
Morningstar DBRS | Sagicor Life Insurance Co., ivari — FSR | A (low), confirmed | Stable | Apr 2026 |
S&P Global | C$350M 2031 notes; C$250M 2029 notes | BBB | — | Sep 2026; Jun 2024 |
Fitch | C$350M 2031 notes | BBB- | — | Sep 2026 |
Moody's | — | Not rated (no rating identified) | — | — |
Capital Instruments
| Instrument | Principal | Coupon | Maturity |
|---|---|---|---|
Senior notes (issued 2021, later upsized) | US$550 million | 5.300% | 13 May 2028 |
Series 2024-1 senior unsecured notes | C$250 million | 6.359% | 20 Jun 2029 |
Series 2026-1 senior unsecured notes | C$350 million | 5.503% | 25 Sep 2031 |
Revolving credit facility (2023) | up to US$125 million | floating | — |
Parent senior notes maturing (USD Mn equivalent, approx.) | FY2028 | FY2029 | FY2031 |
Principal | 550 | 182 | 255 |
Analyst Conclusions
Management guidance. Management targets core ROE of 14% for full-year 2027 and 15% for 2028, with a 30–40% core dividend payout ratio; it describes the current underlying run-rate as approximately 13%. It has guided to one-time charges and investments in Q3 and Q4 2026 related to the Caribbean combination, with synergies and value creation expected through 2027 and 2028, and has flagged possible US reserve strengthening. No explicit 2026 core earnings guidance figure was identified in sources reviewed.
Consensus expectations. Third-party consensus implies P/E of about 7.5x for 2026 and 6.0x for 2027, implying expected EPS growth of roughly 25% from 2026 to 2027 (derived from multiples); dividend yield is expected at about 4.9% (2026E) and 5.4% (2027E) (MarketScreener).
Bull case
-
ROE delivery against a deep discount to book. At approx. 0.77x book and 6–7.5x forward earnings, delivering the 14%/15% core ROE targets would justify a multiple well above book; FY2025 already demonstrated 14.2% core ROE.
-
Caribbean combination unlocks value. Moving from 49.1% to approx. 55% economic ownership of the combined Caribbean business, plus cost and revenue synergies and a cleaned-up balance sheet, should raise both earnings and transparency.
-
Ratings-driven North American growth. AM Best A ratings across operating subsidiaries and the DBRS upgrade broaden US distribution and lower funding costs (2031 notes at 5.503% vs. 6.359% for 2029 notes), while buybacks below book are accretive.
Bear case
-
Earnings quality and volatility. Net income was less than half of core earnings in FY2025, and 2026 YTD core earnings are down 22%; investors may keep discounting "core" until the gap narrows.
-
US legacy block and reserve risk. Q2 2026 US core earnings fell 64% on legacy-block losses; potential reserve strengthening could hit book value and push the 2027 ROE target out.
-
Execution and Caribbean macro risk. Merger slippage into 2027, H2 2026 one-time costs, hurricane exposure, sovereign/FX risk and a declining LICAT ratio (139% → 134%) could constrain capital return.
Catalysts and monitorables (next 12 months)
| Expected timing | Catalyst / monitorable |
|---|---|
| approx. 12 Nov 2026 | Q3 2026 results: size of merger charges; any US reserve strengthening; core ROE vs. 13% run-rate |
| Q4 2026 – H1 2027 | SGC combination approvals and closing; exchange ratio and pro forma ownership confirmation |
| Q4 2026 | Use of proceeds of C$350M notes (e.g., partial 2028 notes refinancing) |
| Mar 2027 | FY2026 results; annual dividend decision (fourth consecutive increase?); updated targets |
| Ongoing | LICAT trajectory (>130% guardrail) and leverage (<30%) |
| Ongoing | US annuity sales trend after A rating upgrade; Canadian mortality experience |
| Jun 2027 | NCIB utilization and renewal |
| Jun–Nov 2027 | Caribbean hurricane season impact |
Analyst verdict
Sagicor Financial has executed a genuine transformation since its 2019 TSX listing. The ivari acquisition — bought at a discount large enough to produce a bargain purchase gain — reshaped the earnings base, and FY2025 delivered core earnings of US$142.3 million and a 14.2% core ROE, a year ahead of management's original timetable. Credit agencies have validated the progress: DBRS upgraded the parent to BBB in April 2026, and AM Best lifted four operating subsidiaries to A (Excellent) in July 2026. Management has responded by raising its ambition to 14% core ROE in 2027 and 15% in 2028, while the Caribbean combination offers a credible route to simplification and synergies.
Yet the market remains sceptical, pricing the shares at roughly three-quarters of book value and well under half of equity-plus-CSM per share. That scepticism is not irrational. Reported net income has been persistently below core earnings, 2026 core earnings are running 22% below 2025, the US legacy life block has produced experience losses with reserve strengthening under consideration, and the group's LICAT ratio has drifted down three years in a row. The heavy head-office cost layer, partial ownership of Jamaica and limited trading liquidity add to the discount, as do Caribbean sovereign and catastrophe risks.
On balance, the risk-reward appears asymmetric in favour of patient investors, provided that management demonstrates three things over the next four to six quarters: closing the SGC combination without material dilution or delay beyond H1 2027; containing US legacy-block issues with a one-time, clearly bounded reserve action rather than recurring drags; and narrowing the gap between core and net income. If these conditions are met, re-rating toward book value or above is plausible on the targeted returns. If they are not, the stock is likely to remain a high-yield, low-multiple value situation rather than a compounder. The Q3 2026 results in November are the next critical checkpoint.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background | Source |
|---|---|---|---|
Andre G. Mousseau | President & Chief Executive Officer; Director | Joined February 2019 as Group CFO; Group COO added August 2021; CEO since 1 April 2023; approximately 20 years of financial services experience at time of 2021 appointment | Company releases (Jul 2021, Jan 2023) |
Kathryn (Kathy) Jenkins | Group Chief Financial Officer | — | Q1/Q2 2026 call transcripts |
George Sipsis | EVP, Corporate Development & Capital Markets (investor relations contact) | — | 2026 news releases |
Paula Walcott | Chief People Officer (based in Bridgetown, Barbados) | Appointed 2024 | Company appointment release (2024) |
Neil Freyke | EVP, Technology & Chief Digital Officer (based in Toronto) | Appointed 2024 | Company appointment release (2024) |
Eric Sandberg | President, Sagicor Life USA | Appointed after Q1 2026 (announced May 2026) | Q1 2026 release |
Robert Trestrail | President & CEO, Sagicor Life Inc. (to continue post-merger) | — | Barbados Today, Dec 2025 |
Christopher Zacca | President & CEO, Sagicor Group Jamaica; designated CEO of Sagicor Group Caribbean | — | Jamaica Gleaner, Dec 2025 |
Ingrid Card | VP, Communications & Brand Experience | — | FY2025 release |
Board of Directors
| Director | Vote for (%) | Notes |
|---|---|---|
Mahmood Khimji | 99.86 | Chair; Alignvest-era sponsor-affiliated director |
Andre Mousseau | 99.90 | President & CEO (non-independent) |
The Most Honourable Dodridge D. Miller | 98.80 | Former CEO (2002–2023); nominated chair of Sagicor Group Caribbean (non-independent) |
Sir Hilary Beckles | 99.95 | — |
Dr. Archibald Campbell | 99.92 | — |
Peter E. Clarke | 99.94 | — |
The Honourable Keith Duncan | 99.94 | — |
Monish Dutt | 99.93 | — |
Dennis L. Harris | 99.95 | — |
Cathleen McLaughlin | 99.92 | Joined 2024 |
Gilbert Palter | 83.97 | Lowest support (16.03% withheld); EdgeStone/Alignvest-era director |
Alan Ryder | 99.98 | — |
Reza Satchu | 99.94 | Alignvest co-founder |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
26 Jan 2023 (effective 1 Apr 2023) | Mousseau succeeds Miller as CEO | Planned succession; Miller remains on board |
| 2023 | CFO search after Mousseau's promotion; Kathy Jenkins in role by 2026 | — |
| 2024 | Paula Walcott (Chief People Officer) and Neil Freyke (EVP Technology & CDO) appointed to Executive Committee | Digital and people agenda |
Dec 2025 | Leadership for Sagicor Group Caribbean designated: Miller (chair), Zacca (CEO); Trestrail continues at Sagicor Life Inc. | Merger governance |
May 2026 | Eric Sandberg appointed President, Sagicor Life USA | To drive continued US growth |
Major Shareholders
| Holder category | Stake | Source |
|---|---|---|
Free float | approx. 68.5% | MarketScreener |
Insiders/strategic holders (implied) | approx. 31.5% (implied by free float) | Derived |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning vs. Sagicor |
|---|---|---|
Caribbean (Sagicor Life / Jamaica) | Guardian Holdings (Trinidad; controlled by NCB Financial Group) | Principal pan-Caribbean life/P&C rival |
Caribbean | NCB Financial Group (Jamaica) | Largest Jamaican financial conglomerate; banking + insurance (via Guardian) |
Caribbean | JMMB Group (Jamaica/Trinidad) | Investment banking and banking competitor |
Caribbean | CIBC Caribbean (FirstCaribbean) | Banking competitor across Barbados/Eastern Caribbean |
Caribbean | Republic Financial Holdings (Trinidad) | Banking competitor |
Caribbean | Massy United Insurance and other regional P&C carriers | General insurance |
Canada (ivari) | Manulife, Sun Life, Canada Life (Great-West Lifeco) | Scale leaders; much larger and more diversified |
Canada | iA Financial, Desjardins, Beneva, RBC Insurance, BMO Insurance | Middle-market and broker-channel competitors |
Canada | Empire Life, Foresters, Equitable Life | Closest mid-sized broker-channel peers (CB Insights lists Empire Life as an ivari competitor) |
United States (annuities) | Athene, F&G Annuities & Life, American Equity, Midland National, Global Atlantic, Delaware Life | Large, often PE/alternative-asset-backed annuity writers |
Peer Comparison FY2025
| Metric | Sagicor (FY2025) | Manulife |
|---|---|---|
Core earnings (USD) | 142.3M | Multi-billion (core ROE mid-teens per Insurance Business, Mar 2026) |
Core ROE | 14.2% | mid-teens |
Revenue growth | -3.0% (company-defined) | — |
R&D intensity | not applicable / not disclosed | not applicable |
P/B (approx.) | 0.77x (Oct 2026) | — |



